Celleo Biotech, a Melbourne-based company, is revolutionizing the world of cell and gene therapy production with a groundbreaking tool. But here's where it gets intriguing: they've adopted INTEGRA's PIPETBOY GENIUS, a serological pipet controller, to enhance reproducibility and efficiency in their processes. This device is a game-changer, offering a repeat dispense function that streamlines liquid handling and saves precious time.
The PIPETBOY GENIUS, when paired with INTEGRA's serological pipets, becomes a powerhouse for accurate and consistent liquid dispensing. This precision is vital for the company's goal of making cell and gene therapies more accessible. Nicholas Boyd, Head of Biology at Celleo Biotech, raves about the instrument's efficiency and ease of use, stating that it simplifies complex cell culture tasks.
And this is the part that most scientists appreciate: the PIPETBOY GENIUS ensures reproducibility, a critical aspect of scientific research. By consistently dispensing precise volumes, it boosts confidence in experimental results. Imagine the impact this could have on the reliability and speed of cell and gene therapy development!
But wait, there's more. INTEGRA Biosciences, the creator of this innovative device, has a track record of ergonomic excellence, as endorsed by iHEALTH 360. They've also been making waves in NGS workflows and are committed to sustainability, aiming for net zero.
Celleo Biotech's choice of the PIPETBOY GENIUS is a testament to its capabilities and potential to transform lab workflows. It's a tool that not only simplifies work but also inspires confidence in the scientific process.
What do you think? Is this the future of cell and gene therapy production? Share your thoughts and let's discuss the potential impact of this technology on the industry.
